(AGENPARL) - Roma, 24 Marzo 2023(AGENPARL) – SILVER SPRING ven 24 marzo 2023 FDA has approved Joenja (leniolisib) tablets as the first treatment for activated phosphoinositide 3-kinase delta syndrome in adult and pediatric patients 12 years of age and older.
Fonte/Source: http://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-treatment-activated-phosphoinositide-3-kinase-delta-syndrome